SureTrader SureTrader
Home > Boards > US OTC > Miscellaneous >

Therapeutic Solutions International, Inc. (TSOI)

Add TSOI Price Alert      Hide Sticky   Hide Intro
Moderator: centsability4me
Search This Board:
Last Post: 10/14/2016 7:13:57 AM - Followers: 81 - Board type: Free - Posts Today: 0

Share Structure - 46M Float
Shares Outstanding 682,751,000 a/o July 13 , 2016
Float 46,312,028 a/o July 13 , 2016
Authorized Shares 995,000,000 a/o July 13 , 2016

Officers and Directors:

Timothy G. Dixon – President, CEO, & Chairman

Mr. Dixon currently serves as Chief Executive Officer, President, and Chairman of Therapeutic Solutions International, Inc. Mr. Dixon also serves as President and Chairman of MolecuVax, Inc., President and Chairman of OmniBiome, Inc., and President and Chairman of Capo Therapeutics, Inc. Mr. Dixon previously served as the President of TMD Courses, Inc. from 2006 to 2012 and; as the President of Splint Decisions Inc. from 2010 to 2011. Mr. Dixon has attended hundreds of hours of continuing medical/dental education throughout the years and has produced many educational DVD’s used by dental professionals worldwide on the subject of parafunctional control, migraine prevention, therapeutic Botox injections, migraine pathophysiology, dental sleep medicine, and other therapeutic protocols. Mr. Dixon also has extensive experience in dealing with corporate compliance matters with the U.S. Food and Drug Administration, (FDA) as well as many international regulatory bodies.

Gerry B. Berg – Vice President, CFO, Director

Gerry B. Berg has served as our Vice-President and Chief Financial Officer since April 20, 2011.  Mr. Berg became a director of the Company on August 24, 2012.  Mr. Berg also serves as Chief Financial Officer of MolecuVax, Inc, OmniBiome, Inc, and Capo Therapeutics, Inc. Mr. Berg has over 30 years of senior management experience working with private and public companies.  From May 2010 to March 2011, Mr. Berg served as President and Chairman of the Board of Directors of Friendly Auto Dealers, Inc. and also served in a consulting capacity from March 2009 to May 2010.
Mr. Berg holds a Bachelors of Science in Accounting from Walsh College where he graduated Cum Laude.  Mr. Berg became a Certified Public Accountant in the State of Michigan in 1979 and in the State of California in 1984.  Mr. Berg does not currently practice as a Certified Public Accountant.

Thomas E.Ichim, Ph.D – Director

Dr. Ichim was appointed to the Board of Directors on January 22, 2016.  Dr. Ichim is a seasoned biotechnology entrepreneur with a track record of scientific excellence. He has founded/co-founded several companies including Batu Biologics, Inc., Medvax Pharma Corp, ToleroTech Inc, bioRASI, and OncoMune LLC. To date he has published 99 peer-reviewed articles and is co-editor of the textbooks “RNA Interference: From Bench to Clinical Translation” and “Immuno-Oncology Text Book.”
Dr. Ichim is an ad-hoc editor and sits on several editorial boards. Dr Ichim is inventor on over 50 patents and patent applications. Dr. Ichim has extensive experience with stem cell therapy and cellular product development through FDA regulatory pathways. Dr. Ichim spent over 7 years as the President and Chief Scientific Officer of Medistem, developing and commercializing a novel stem cell, the Endometrial Regenerative Cell, through drug discovery, optimization, preclinical testing, IND filing, and up through Phase II clinical trials with the FDA. Dr. Ichim has extensive experience in product development, regulatory filings, and business development.
Dr. Ichim has a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada, a MSc in Microbiology and Immunology a University of Western Ontario, London, Ontario, Canada and a Ph.D in Immunology from the University of Sciences Arts and Technology, Olveston Monserrat.


Hong Ma, MD, Ph.D., M.B.A. – Chief Scientific Officer

Dr. Ma has an extensive history in academic and translational research. Subsequent to completing her medical degree, she performed basic research in the area of molecular biology of endothelial-associated pathways in her doctorate and postdoctoral studies. She has been critical in establishing numerous ventures and collaborations in the area of biosciences. Dr. Ma has over 20 peer-reviewed publications and has worked with prestigious institutions in the USA, China, and Japan. She received her M.D. from Dalian Medical University, her Ph.D in Cardiovascular Pharmacology at Asahikawa Medical College, and has also earned her MBA at the Rady School of Management at the University of California San Diego.

Therapeutic Solutions International, Inc. Subsidiaries and Divisions

As of July 20, 2016 TSI owns approximately 73.75% of the outstanding shares of OmniBiome, Inc. See
As of July 20, 2016 TSI owns approximately 21.5% of the outstanding shares of MolecuVax, Inc. See
As of July 20, 2016 TSI owns approximately 6.5% of the outstanding shares of Capo Therapeutics, Inc. See

Contact Info:

CEO email address:  

Therapeutic Solutions International, Inc.
4093 Oceanside Blvd Suite B
Oceanside CA 92056



Disclaimer : All of the information presented in the IBOX , Stickies , or postings on this board is based on individual opinions , and is not to be considered as a recommendation to buy , sell , or hold this stock .

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
TSOI News: Small Company Offering and Sale of Securities Without Registration (d) 09/19/2016 02:37:08 PM
TSOI News: Quarterly Report (10-q) 08/23/2016 06:04:20 AM
TSOI News: Current Report Filing (8-k) 07/28/2016 01:48:02 PM
TSOI News: Quarterly Report (10-q) 07/26/2016 04:02:15 PM
TSOI News: Therapeutic Solutions International Reports Augmentation of Cancer Immunotherapy using Pterostilbene 07/11/2016 09:44:57 AM
#5622   There should be another filing coming out soon cantbelieveit 10/14/16 07:13:56 AM
#5621   a good hold for us here. News will LoveItInBishop 10/10/16 01:35:03 PM
#5620   no trades for a week !!! corvatsch 10/04/16 02:38:11 PM
#5619   CAPOs website has been down all week for cantbelieveit 09/28/16 07:04:02 PM
#5618   Dr. Santosh Kesari added to MVAX SAB centsability4me 09/16/16 09:44:43 AM
#5617   News due soon. Should see this go back up LoveItInBishop 09/09/16 03:01:32 PM
#5616   Yes Dr. Ichim centsability4me 09/07/16 02:23:19 PM
#5615   5 articles centsability4me 09/07/16 02:07:31 PM
#5614   does not exchange ? problems corvatsch 09/07/16 01:30:14 PM
#5613   He's a very impressive man to lead MVAX. cantbelieveit 08/30/16 05:14:01 PM
#5612   Dr. Ichim DD centsability4me 08/30/16 09:10:44 AM
#5611   Dr. Thomas Ichim is the new CEO of Molecuvax centsability4me 08/30/16 08:52:34 AM
#5610   Leisha Emens M.D. DD centsability4me 08/29/16 08:22:06 AM
#5609   Dr. Edward Nelson DD centsability4me 08/29/16 08:09:03 AM
#5608   Nice find cents. Thank you for posting:) cantbelieveit 08/28/16 07:09:48 PM
#5607   Molecuvax has new SAB members centsability4me 08/27/16 09:19:48 AM
#5606   10Q Out this morning for Sept 2015. cantbelieveit 08/23/16 07:04:50 AM
#5605   TSOI Update centsability4me 08/18/16 09:11:09 AM
#5604   i admit i'm surprised too, but anyway is ita-elios 08/15/16 03:33:18 PM
#5603   does not exchange share ??? corvatsch 08/15/16 01:41:49 PM
#5602   I do agree with your projections. The cantbelieveit 08/10/16 05:06:36 PM
#5601   a little more volume centsability4me 08/09/16 03:23:11 PM
#5600   Yes, can't wait to see more filings submitted cantbelieveit 08/09/16 12:13:39 PM
#5599   nice close yesterday centsability4me 08/09/16 09:36:46 AM
#5598   TSOI ownes 6.5 million shares. The ipo Olde English 800 08/07/16 01:11:53 PM
#5597   thanks and good luck to all corvatsch 08/06/16 02:26:17 PM
#5596   corvatsch , centsability4me 08/06/16 12:14:44 PM
#5595   amazing good..... corvatsch 08/03/16 01:41:25 PM
#5594   this gem won't be centsability4me 08/03/16 01:08:06 PM
#5593   I only check in when I see something cjstocksup 08/03/16 01:01:23 PM
#5592   well centsability4me 08/03/16 12:54:59 PM
#5591   I noticed. TSOI has been one of the cjstocksup 08/03/16 12:51:46 PM
#5590   the exposure level of CAPO centsability4me 08/03/16 12:50:21 PM
#5589   TSOI back at .01. cjstocksup 08/03/16 12:44:20 PM
#5588   bionutratherapeutical conglomerate lol centsability4me 08/03/16 12:40:18 PM
#5587   And that's only taking into account the one cantbelieveit 08/03/16 09:44:31 AM
#5586   Figuring a takeover price centsability4me 08/03/16 09:25:22 AM
#5585   Where should I put that 200k in the ad1 08/02/16 08:35:01 PM
#5584   Nice close....200k all day @75 bid, but nobody ita-elios 08/02/16 04:04:04 PM
#5583   CAPO SAB member Dr. Lon Schneider centsability4me 08/02/16 09:37:04 AM
#5582   CAPO SAB member Dr. M. Flint Beal centsability4me 08/02/16 09:28:50 AM
#5581   and we should be hearing from OMNI also centsability4me 08/02/16 09:24:14 AM
#5580   CAPO SAB member Dr. David Cribbs centsability4me 08/02/16 09:17:10 AM
#5579   That's wonderful news. I would think we cantbelieveit 08/02/16 09:13:30 AM
#5578   CAPO-related government grants existing : centsability4me 08/02/16 09:11:55 AM
#5577   What is CAPO about ? centsability4me 08/02/16 08:59:37 AM
#5576   CAPO exposure increasing Worldwide : centsability4me 08/02/16 08:19:05 AM
#5575   and mentioned centsability4me 08/01/16 12:08:41 PM
#5574   THE WORD IS OUT ON CAPO, centsability4me 08/01/16 11:45:32 AM
#5573   That's what I see... cantbelieveit 07/28/16 02:19:30 PM